Clinical Trials Logo

Clinical Trial Summary

Zopiclone, a widely used hypnotic drug, is frequently found in blood samples taken from drivers suspected of driving under the influence. In this study, the investigators aim to correlate zopiclone serum concentrations with degrees of driving impairment in healthy volunteers by use of a validated driving simulator. The investigators also aim to compare their results with the results from a previous study that investigated zopiclone impairment of cognitive and psychometric tests.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)


Related Conditions & MeSH terms


NCT number NCT01257165
Study type Interventional
Source St. Olavs Hospital
Contact
Status Withdrawn
Phase N/A
Start date August 2012
Completion date December 2012

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05096000 - InterMob: a Randomized Controlled Trial Aimed at Reducing Car Use in Regular Car Users N/A
Completed NCT00967421 - Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs. N/A
Recruiting NCT05163119 - Randomized Trial on Mobile Technology and Young Drivers' Cellphone Use N/A
Recruiting NCT06290037 - Driving Ability Evaluation System to Improve the Conditional Driving License System: Feasibility Study of High-risk Drivers. N/A
Recruiting NCT06279520 - Driving Ability Evaluation System to Improve the Conditional Driving License System: Safety and Feasibility Study. N/A